Dr. Robbins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3838 N Campbell Ave
Bldg 2
Tucson, AZ 85719Phone+1 520-694-2873Fax+1 520-694-0197
Summary
- Dr. Jared Robbins is a radiation oncologist in Tucson, AZ and is affiliated with multiple hospitals in the area, including Clement J. Zablocki Veterans Affairs Medical Center, Banner - University Medical Center Tucson, and Southern Arizona Veterans Affairs Health Care System. He received his medical degree from University of Arizona College of Medicine-Tucson and has been in practice 13 years. He specializes in gastrointestinal cancer, head & neck, and skin cancer and is experienced in cancer of the oral cavity and oropharynx, squamous cell carcinoma of the oropharynx, squamous cell carcinoma of the hand and wrist, squamous cell carcinoma of the floor of the mouth, and squamous cell carcinoma of the buccal mucosa.
Education & Training
- Henry Ford Health/Henry Ford HospitalResidency, Radiation Oncology, 2009 - 2013
- Medical College of Wisconsin Affiliated HospitalsInternship, Internal Medicine, 2008 - 2009
- University of Arizona College of MedicineClass of 2008
Certifications & Licensure
- AZ State Medical License 2018 - 2025
- NC State Medical License 2024 - 2025
- WI State Medical License 2013 - 2019
- MI State Medical License 2009 - 2013
- American Board of Radiology Radiation Oncology
- AOA Board of RadiologyRadiation Oncology
Awards, Honors, & Recognition
- Educator of the year Association of Residents in Radiation Oncology, 2016
Publications & Presentations
PubMed
- Getting Cheeky With It: Adult Rhabdomyosarcoma.Christopher M Morrison, Jared R Robbins
International Journal of Radiation Oncology, Biology, Physics. 2025-01-01 - 1 citationsRadiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label,...Loren K Mell, Pedro A Torres-Saavedra, Stuart J Wong, Julie A Kish, Steven S Chang
The Lancet. Oncology. 2024-12-01 - Key factors for establishing and sustaining a successful palliative radiation oncology program: a survey of the Society for Palliative Radiation Oncology.Deborah C Marshall, Kavita Dharmarajan, Randy Wei, Yolanda D Tseng, Jessica Schuster
Annals of Palliative Medicine. 2024-07-01
Journal Articles
- Technical Note: Enhancing Soft Tissue Contrast and Radiation Induced Image Changes with Dual‐Energy CT for Radiation TherapyJared Robbins, MD, Medical Physics
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: